A major part of the stories of #iamthefaceofMAID is that some health conditions are NOT recognized and/or treated in Canada (like MCS and hEDS). BUT!!! They are recognized by #MAID. This is THE disconnect Canada! This is why we need to talk about #IamthefaceofMAID 1/n
If #MAID will recognize conditions, like #MCS and #hEDS, and there are not even specialists in Canada that treat those conditions. Well, we have a problem.
2/n
The #hEDS community struggles every day, thousands of us, for treatment that we know is available but it is not offered in Canada. Often we travel to the US for diagnosis because there are so few specialists in Canada. The surgeries needed are not offered in Canada. 3/n
As a #hEDS patient with CCI and cervical stability issues I cannot even get the right type of MRI in Canada through medical services (a flexion-extension MRI) to be diagnosed properly. The only one in BC is in Kamloops and is not covered by BC medical. 4/n
Let me repeat. I cannot even get a proper diagnosis in Canada for my condition because we dont have the right MRI machines. No Canadian Neurosurgeons will even see #hEDS patients or look at their scans (we have all tried). 5/n
Our only option is 100K cervical surgery offered by two specialists in the US. The full expense of this would be born by the patient. Unfortunately many of us are simply too sick to travel for diagnosis and treatment and based on the cost it is out of reach for most families. 6/n
When I realized the women in the Simon's commercial was 36 and had already been euthanized and that we shared a diagnosis - its hard to describe how I felt - I was torn apart. I know each step she followed to get where she went and each thing that happened to me 7/n
to ensure that my path went in a different direction. I was her, I could be her. I could still be her. That things wont suddenly go downhill for me again is not a given. My health is very poor but somewhat controlled. Tomorrow, who knows. 8/n
#hEDS is a condition that most dont find about until their 30s or 40s after 20+ specialists and doctors. There is no reason for this. Its not a hard condition to diagnose. It should have been done when I was a child - when lifestyle changes could have made a difference. 9/n
My own diagnosis was by chance. A visiting specialist in #EDS from England was doing a sabbatical at the Genetics Center in Halifax when I had my appointment - they did a Beighton test right at the end of my appointment when they saw how much compression gear I wore. 10/n
This was in 2017. I was 43 when I was diagnosed after years of dragging myself from specialist to specialist all the while getting sicker and being told time and time again it was all in my head (and I was a tenured Biology professor at a major research university!). 11/n
Oxidative stress is often portrayed as being similar to 'rust' but a much better analogy is acid rain or a corrosive liquid. Reactive oxygen species (ROS) dont cause a build up - like with rust - instead they eat away at the cell's components and damage structure, including DNA. 1/x
The latest paper from Dr. Ron Davis lab shows that in both ME and LongCovid oxidative stress in immune cells is higher than in controls. Importantly ROS was even higher in female patients.
2/xbiorxiv.org/content/10.110…
Of course the body has a protective mechanism for too much ROS - endogenous antioxidants - in particular Glutathione (GSH). Glutathione was also higher in patients suggesting that this pathway is overworked. 3/x
Current preclinical research indicates that BPC-157 is not only unlikely to cause anhedonia but may actually PROTECT against depressive symptoms.
Anhedonia = inability to feel/experience pleasure (one aspect of depression that is ALSO very common in people who use anti-depressants such as SSRIs).
Here are several lines of evidence (Chat GPT):
Antidepressant Effects in Animal Models
In forced swimming tests (a standard model for assessing depression‐like behavior), BPC-157 administration significantly reduced immobility time in rats. This reduction is comparable to that seen with traditional antidepressants like imipramine, indicating that BPC-157 has robust antidepressant properties rather than depressogenic effects.
These findings suggest that, mechanistically, BPC-157 is protective against the development of depressive symptoms rather than causing anhedonia.
Modulation of Neurotransmitter Systems
BPC-157 has been shown to interact beneficially with several key neurotransmitter systems:
Serotonin: Research demonstrates that BPC-157 can stimulate serotonin release in specific brain regions (e.g., the nigrostriatal area) and even counteract serotonin syndrome. Enhanced serotonin neurotransmission is generally associated with improved mood and is a common target of antidepressant therapies.
Dopamine: BPC-157 also modulates dopamine activity. It counteracts behavioral disturbances (like neuroleptic-induced catalepsy) that are linked to dopaminergic dysregulation. Given that dopamine plays a key role in reward and motivation, its proper modulation by BPC-157 supports a healthy reward system rather than one that would lead to anhedonia.
Other Systems:
Additionally, BPC-157 appears to influence glutamate and GABA systems in a way that promotes overall neural homeostasis.
Together, these actions support a neurochemical environment that is conducive to normal mood regulation and motivation.
Anti-inflammatory and Neuroprotective Actions
Inflammation—both systemic and within the brain—has been strongly implicated in the pathophysiology of depression. BPC-157 is known for its potent anti-inflammatory and cytoprotective effects, including in neural tissues. By reducing brain inflammation, BPC-157 may help prevent or mitigate neuroinflammatory processes that can lead to depressive symptoms.
Mechanistic Rationale
The peptide’s overall mechanism:
**enhancing endothelial function
**promoting angiogenesis
**stabilizing cellular integrity
supports its role as a cytoprotective agent.
Such effects not only improve tissue repair and recovery after injury but also support the overall health of the brain’s neurovascular unit. A well-maintained neurovascular environment is critical for normal neurotransmission and has been associated with resistance to depression and anhedonia.
Summary:
The preclinical evidence suggests that BPC-157 is unlikely to cause anhedonia. On the contrary, by enhancing serotonin and dopamine function, reducing neuroinflammation, and promoting neuroprotection, BPC-157 may actually offer protective and even therapeutic benefits in depressive conditions.
TR: I know there are some Reddit posts with users claiming that BPC caused anhedonia. Sure, it is possible - but based on the above and the mechanisms of action it is just very unlikely - it is much more likely that something else was causing the depression and that BPC actually was minimizing it. I know its hard sometimes to make the right links with interventions but we need to fall back to the mechanisms. If something is likely to be protective - then well....it is not very likely to be damaging. Right? What else were they doing? Do they have histories of depression?
The peptide primer (focusing on using peptides for Hypermobility/hEDS and connective tissue issues)
I have seen many cases where the addition of BPC-157 is what stopped the cycle of decline in MECFS.
Management in chronic disease is NOT a "One and Done".
If the trigger is still maintaining the disease, the issue has not be fixed - its just been controlled - and to keep up the desired state of function - you need to keep up the treatment and management.
Does this make sense?
One of the key issues in MECFS and similar conditions is sensitivity and reactivity. There are MANY reasons why we have more side-effects and lower tolerance to medication but a major MAJOR MAJOR one is actually leaky gut itself.
Just like our body freaks out when the endotoxins from bacteria leak out of our gut lining - our body also freaks out when meds leak out into the blood stream.
They are not being processed in the normal way. They get into the body too fast, in too high of an amount, they are processed too quickly, the normal co-factors and processing pathways cant kick in so they do abnormal stuff.
There are many ways that leaky gut impacts reactivity and sensitivity but because LEAKY GUT itself (and the MCAS-leaky gut-microglial feedback loops that maintain it) is an issue - this means that most of us actually feel like we don't respond well or normally to medications. I think actually that most of us would answer this question in the affirmative, especially as severity increases:
Do you feel like you are more sensitive and reactive to medications, supplements, and interventions than people that do not have ME or LC or a similar condition? As we get more severe sensitivity becomes more likely (or so it seems to me) and by the time you hit moderate/severe - it probably feels like every new supplement or medication is a risk.
But why? right? why are we more sensitive? Its actually not just leaky gut - there is a lot more going on - but the THREE processes below are important:
**Depending on ones particular situation they might need many MANY times LESS of a medication to equal the dose that a non-leaky gut person would need. **They might get a huge bolus-like dose (i.e. all at once) versus the slower entry of the substance that non-leaky gut people experience.
**Because of MCAS and autoimmunity our bodies mistake more substances as potentially dangerous.
Regardless of the particulars - the key is to TREAT leaky gut. And keep treating it.
If the pedal is still on the metal (i.e. the triggers of the condition are still present - including MOLD/fungus, LPS, viruses, bacteria, chemicals) you will likely need to Treat Leaky GUT and then MAINTAIN the gut so that leaky gut does not re-occur.
Does this make sense? Management in ME and similar conditions is not a One and Done. It is management.
Here is some advice: 1. Work leaky gut treatment into your general protocol. its an ongoing management issue. 2. Best way to do this IMO is BPC-157. You can cycle on and off. 3. If you are still SICK - the process that drives leaky gut is still operating. This means that we must MANAGE it. Its not a one and done. It can come back.
Because BPC-157 is a great systemic anti-inflammatory it could be the type of intervention that replaces a whole slew of other common interventions for you. If it works for you and you dont react to it - use it as a basis of your treatment protocol - build on it. It will not cure ME but without directly managing leaky gut - it is hard for other interventions to work. BPS-157 can be like the foundation - that helps other interventions be effective (or more effective).
I see many cases where BPC-157 started the shift in baseline increase.
The addition of BPC-157 is often what stops the cycle of decline.
I actually first started posting on X (then twitter) because of my experience with peptides in stabilizing #hEDS. They were one of the main game changers for me. I really don't have obvious connective tissue issues the way I once did.
Mixing up ones own electrolyte mix seems to be a major barrier for getting started with Born Free protocol and electrolyte supplementation in general.
With the help of ChatGPT I have put together a more commercially based mix of products that hits all the Born Free targets.
The main potassium core is Dr. Berg's electrolyte mix. We then add Nutri-Align capsules, Now foods Red Mineral Algae, and Himalayan/Celtic Salt and Baking Soda.
It will be many times the cost of buying the bulk powders but if it is easier - and means people will be more likely to use it - then its worth considering. 1/x
Electrolyte Needs in ME/CFS, Chronic Infections, and Post-Viral Syndromes (versus needs in Healthy people)
Electrolytes play a critical role in cellular energy production, nerve function, hydration, and blood pressure regulation. In ME/CFS and chronic illness, electrolyte imbalances are common due to autonomic dysfunction (POTS, dysautonomia), mitochondrial dysfunction, poor absorption, chronic inflammation, and infections.
People with ME/CFS, post-viral syndromes, and high pathogen loads (bacteria, fungi, viruses, mold toxicity) often require significantly higher electrolyte intake than standard RDAs, particularly sodium, potassium, magnesium, bicarbonate, and phosphate to maintain blood volume, support ATP production, and counteract inflammatory depletion.
Chat GPT
2. Electrolyte RDAs vs. ME/CFS-Specific Needs
The table below compares standard RDAs with the estimated optimal intake for someone with severe ME/CFS, considering widespread electrolyte depletion, mitochondrial dysfunction, and immune activation.
How Do Nutrient, Vitamin, and Mineral needs differ for those with chronic Illness (ME/CFS, LongCovid Post-Viral Syndromes, and persistent infections) than for healthy people?
People with chronic illnesses, especially post-viral conditions like ME/CFS, have significantly altered nutrient demands compared to healthy individuals due to persistent infections, high bacterial and fungal loads, mitochondrial dysfunction, and chronic inflammation. These factors increase nutrient depletion, impair absorption, and alter metabolism, making the standard Recommended Dietary Allowances (RDAs) insufficient for optimal function.